Insurers Spend Big to Save Obamacare Subsidies at Center of Shutdown Fight

Ominous images of anxious adults and children began flashing on streaming services and social media more than a week before Senate Democrats forced a government shutdown over their demands to renew expiring Obamacare insurance subsidies.

“Health care costs will skyrocket,” the advertisements warn, urging Americans to “Tell Congress” to act to continue the tax credits as the video shifts to a view of the Capitol building.

Health insurers, long concerned a spike in insurance premiums triggered by the subsidies’ expiration will drive away millions of customers, is seizing the moment as their best shot at heightening public attention to their message.

The advertising campaign, running across Hulu, Google and Facebook, kicked off on Sept. 20 as congressional Democrats threatened to shut down the government in part over extending the Affordable Care Act’s enhanced premium tax credits, which help lower the cost of health-insurance premiums for roughly 22 million Americans.

Only insurance lobbyists and allied health care advocates have adopted a distinctly bipartisan approach, enlisting at least one Republican strategist and emphasizing GOP-friendly arguments to further their cause.

“We are laser-focused on protecting access to high-quality, affordable health care—and working with policymakers to make it happen,” said David Merrit, senior vice president of external affairs for the Blue Cross Blue Shield Association, which paid for the advertising campaign.

Their bet is that a lobbying offensive can ease the way for an agreement to renew the Obamacare subsidies as either a pathway out of the shutdown or a political priority afterward.

One fact sheet circulated to congressional offices by some in the industry estimates 19 million of the people with coverage that could be impacted live in states that President Donald Trump won in 2024.

“This is big in rural communities, farmers, ranchers, small business owners and small business workers,” said Brendan Buck, communications director for Keep Americans Covered, a coalition that includes health insurance companies as well as the American Medical Association, American Lung Association, and other health care advocates.

“There’s a natural constituency there,” said Buck, a well-known Republican strategist who served former House Speakers Paul Ryan and John Boehner. “I think Republicans see the political risk of allowing this to happen, particularly when the fight for the midterms is so intense.”

 

Source Link

Recommended Articles

CMS Finalizes Major Changes To ACA Exchanges, Including Greater Access To Catastrophic Plans

Editor’s Note: Covered California is a State-Based Marketplace (SBM). For details on how these new rules will impact Covered California and other SBMs we recommend the following Princeton University linked report: (Broker rule changes appear at the bottom of the Princeton analysis.) https://shvs.org/wp-content/uploads/2025/06/SHVS_2025-Final-Marketplace-Integrity-Rule.pdf.   The Trump administration on Friday finalized a major rule reshaping the ...

Read More

Eroding ACA Enrollment Portends Higher Insurance Rates

Enrollment in the Affordable Care Act continues to erode as some customers struggle to make premium payments, with the declining numbers churning market uncertainty for insurers. In response, insurers are likely to raise rates again next year, following this year’s larger-than-typical hikes. Sign-ups were already down in January by about 1.2 million from last year’s record enrollment. For ...

Read More

White House Adds Generic Drugs To Direct-To-Consumer TrumpRx Site

The Trump administration on Monday said it is adding generic medications to its direct-to-consumer drug sales website, TrumpRx, in a bid to expand a platform that is key to his administration’s efforts to lower prescription drug costs in the U.S. The administration is adding more than 600 generic drugs to the site, President Donald Trump said at an event ...

Read More

Supreme Court Rejects Big Pharma Appeals Challenging Negotiated Drug Prices In Medicare

The US Supreme Court on Monday rejected a series of appeals from several of the nation’s largest drugmakers challenging a program that is expected to save taxpayers and the federal government billions of dollars by requiring the companies to negotiate with Medicare on the prices for some of their most popular drugs. The court’s decision to deny ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square